RDHL RedHill Biopharma Ltd: Nilai Buku Perusahaan

Logo perusahaan publik RedHill (RDHL)

The market valuation chart for RedHill Biopharma (RDHL) reflects the dynamics of its gastrointestinal treatment business, where the indicator stands at -0.00. Optimization of component delivery routes eliminates supply chain disruptions. Stable cash flow is driven by physician loyalty to the current product portfolio. Meanwhile, a significant portion of clinical trials and distribution has been outsourced to third-party contractors, creating a pronounced dependency on partners.

RDHL - Kapitalisasi Buku RedHill Biopharma Ltd. ing rentang 04.07.2022 - 29.10.2026

RDHL (RedHill): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:
Bagan owah-owahan rega RedHill Biopharma|RDHL - Bagan rega target
- data kapitalisasi saham perusahaan:
Nilai pasar RedHill Biopharma Ltd|RDHL - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku Saham RedHill Biopharma|RDHL - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku redhillbio.com|RDHL - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal RedHill Biopharma|RDHL - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal RedHill Biopharma|RDHL - Utang perusahaan|Utang marang nilai buku RedHill Biopharma Ltd|RDHL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan RedHill Biopharma|Rasio jangkoan perantara redhillbio.com
Analisis wiwitan perusahaan:RedHill Biopharma
Produk seri redhillbio.com

Book value capitalization reflects the difference between total assets and liabilities, allowing an investor to assess the real value of equity while accounting for tax effects and liquidity. The trend in the book value of net assets for RedHill Biopharma (RDHL) demonstrates the financing efficiency of its targeted antibiotic developments, confirming the business's financial stability in creating innovative drugs for critical hospital settings.

Analisis pesaing RedHill Biopharma

Nilai Akuntansi Perusahaan PHAT (Phathom)|Terns Pharmaceuticals (TERN) - Nilai Buku Perusahaan|IRWD (Ironwood Pharmaceuticals, Inc.) - Nilai Buku Perusahaan|Nilai Buku Perusahaan Curanex Pharma|Immuron Inc - Nilai Aset Bersih|Kapitalisasi Buku EVOK|ENTO (enterothera.com) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku PALI (Palisade Bio, Inc.)|Kapitalisasi Buku jaguar.health JAGX|BIOR - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan MORF (Morphic Therapeutic)